Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 4, 2023 · 10-Q · 34 days after period end · 0001213900-23-036113
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$9.05M | -$10.76M | -$13.47M | -$10.06M |
| EPS Diluted | -$0.80 | -$0.96 | -$1.20 | -$1.81 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 4, 2023 · 34 d after period end
